tert-butyl (1-cyclohexyl)aminosulfonylcarbamate | 147715-84-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机硫酸及其衍生物
• 英文名称: tert-butyl (1-cyclohexyl)aminosulfonylcarbamate
• 英文别名: tert-butyl N-(cyclohexylsulfamoyl)carbamate
• CAS: 147715-84-2
• 化学式: C₁₁H₂₂N₂O₄S
• 分子量: 278.373
• InChiKey: GFNWYRGNEVUSQS-UHFFFAOYSA-N

物化性质

• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  92.9
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  tert-butyl (1-cyclohexyl)aminosulfonylcarbamate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 N-环己基硫二酰胺
  参考文献：
  名称：

  碳酸酐酶抑制剂：用磺酰胺衍生物抑制胞质同工酶I和II。

  摘要：

  从非常弱的碳酸酐酶抑制剂（CAI）磺酰胺开始，已经鉴定出一类新型的有效CAI，最近已报道了其与hCA II加合物的X射线晶体结构。由相应的胺和N-（叔丁氧羰基）-N- [4-（二甲基氮杂亚苄基）-1,4-二氢吡啶基-1-基磺酰基]氮杂酰胺制备了一系列N，N-二取代-和N-取代的磺酰胺或不稳定的N-（叔丁氧羰基）氨磺酰氯。双取代的化合物太大，不能用作CAI，而单取代的衍生物（包括脂肪族，环状和芳香族部分）以及双磺酰胺则充当两种胞质同工酶hCA I和hCA II的微纳摩尔抑制剂。 ，负责高等脊椎动物的关键生理过程。芳基磺酰胺比脂族衍生物更有效。已经检测到低纳摩尔抑制剂，其通常在其分子中掺入4-取代的苯基部分。这是CAI的第一个例子，其中从非常无效的铅分子开始生成低纳摩尔抑制剂。

  DOI：

  10.1016/s0960-894x(03)00028-3
• 作为产物：
  描述：

  环己胺 、 N-(叔丁氧基羰基)磺酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 tert-butyl (1-cyclohexyl)aminosulfonylcarbamate
  参考文献：
  名称：

  含膦酸酯部分的新型 N-酰基磺酰胺的便捷合成

  摘要：

  图形摘要 摘要 本研究描述了一种合成含有膦酸酯部分的新型 N-酰基磺酰胺的简便方法。N-酰基磺酰胺以氯磺酰基异氰酸酯 (CSI) 为原料，分四步（氨基甲酰化、氨磺酰化、脱保护和酰化）制备。亚磷酸三甲酯已用于通过 Arbuzov 反应将膦酸酯部分引入 N-酰基磺酰胺中。

  DOI：

  10.1080/10426507.2014.931398

文献信息

• FLUORO-SUBSTITUTED 3,4-DIARYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDINE DERIVATIVES HAVING CB1-ANTAGONISTIC ACTIVITY
  申请人：Lange Josephus H.M.

  公开号：US20110172274A1

  公开（公告）日：2011-07-14

  This invention concerns fluorinated 3,4-diaryl-4,5-dihydro-1H-pyrazole-1-carboxamidine derivatives as cannabinoid-CB 1 receptor antagonists, methods for preparing these compounds, novel intermediates useful for the synthesis of said compounds, methods for the preparation of these intermediates, pharmaceutical compositions containing one or more of these dihydropyrazole derivatives as active ingredient, as well as the use of these pharmaceutical compositions for the treatment of obesity and obesity-related cardiovascular disorders, drug addiction, cognition deficits, liver fibrosis and inflammatory disorders. The compounds have the general formula (I) wherein the symbols have the meanings given in the specification.

  本发明涉及氟化的3,4-二芳基-4,5-二氢-1H-吡唑-1-羧酰胺衍生物，作为大麻素CB1受体拮抗剂，制备这些化合物的方法，用于合成上述化合物的新型中间体，制备这些中间体的方法，含有一种或多种这些二氢吡唑衍生物作为活性成分的制药组合物，以及利用这些制药组合物治疗肥胖和肥胖相关心血管疾病、药物成瘾、认知缺陷、肝纤维化和炎症性疾病的用途。这些化合物的一般式为(I)，其中符号的含义在说明书中给出。
• A new family of potential oncostatics: 2-chloroethylnitrososulfamides (CENS)—I. Synthesis, structure, and pharmacological evaluation (preliminary results)
  作者：Mohamed Abdaoui、Georges Dewynter、Nourredine Aouf、Gilles Favre、Alain Morère、Jean-Louis Montero

  DOI：10.1016/0968-0896(96)00118-6

  日期：1996.8

  A new series of alkylating agents, 2-chloroethylnitrososulfamides (CENS), were developed on the model of 2-chloroethylnitrosoureas. Starting from chlorosulfonyl isocyanate, a four-step synthesis (carbamoylation-sulfamoylation, Mitsunobu alkylation, deprotection, and nitrosation) gives the title compounds in a 47-58% overall yield. The selection of the nitrosation site can be directed through an alternative route. The pharmacological evaluation shows a significant oncostatic activity towards both A549 and MCF7 cell lines. Copyright (C) 1996 Elsevier Science Ltd
• An Efficient Method for the Synthesis of Novel N-acylsulfonamides Using Tin (IV) Chloride as Catalysts
  作者：Fouzia Bouchareb、Wahida Boufas、Hadjer Cheloufi、Malika Berredjem、Nour-Eddine Aouf

  DOI：10.1080/10426507.2013.843000

  日期：2014.5.4

  A series of novel N-acylsulfonamides derivatives were synthesized via direct condensation of parent sulfonamide with ethyl lactate as an acylating agent in the presence of tin (IV) chloride (SnCl4) as a Lewis acid catalyst. The sulfonamides were prepared, starting from chlorosulfonyl isocyanate (CSI), in three steps (carbamoylation, sulfamoylation, and deprotection) with excellent yields.
• Synthesis and antibacterial activity of sulfonamides. SAR and DFT studies
  作者：Wahida Boufas、Nathalie Dupont、Malika Berredjem、Kamel Berrezag、Imène Becheker、Hajira Berredjem、Nour-Eddine Aouf

  DOI：10.1016/j.molstruc.2014.05.066

  日期：2014.9

  A series of substituted sulfonamide derivatives were synthesized from chlorosulfonyl isocyanate (CSI) in tree steps (carbamoylation, sulfamoylation and deprotection). Antibacterial activity in vitro of some newly formed compounds investigated against clinical strains Gram-positive and Gram-negative: Escherichia coli and Staphylococcus aureus applying the method of dilution and minimal inhibition concentration (MIC) methods. These compounds have significant bacteriostatic activity with totalities of bacterial strains used. OFT calculations with B3LYP/6-31G(d) level have been used to analyze the electronic and geometric characteristics deduced for the stable structure of three compounds presenting conjugation between a nitrogen atom N through its lone pair and an aromatic ring next to it. The principal quantum chemical descriptors have been correlated with the antibacterial activity. (C) 2014 Elsevier B.V. All rights reserved.
• Convenient Synthesis of Novel <i>N</i>-Acylsulfonamides Containing Phosphonate Moiety
  作者：Wahida Boufas、Hadjer Cheloufi、Fouzia Bouchareb、Malika Berredjem、Nour-Eddine Aouf

  DOI：10.1080/10426507.2014.931398

  日期：2015.1.2

  Abstract The present study describes a convenient method for the synthesis of new N-acylsulfonamides containing phosphonate moiety. The N-acylsulfonamides were prepared starting from chlorosulfonyl isocyanate (CSI) in four steps (carbamoylation, sulfamoylation, deprotection, and acylation). Trimethylphosphite has been used to introduce the phosphonate moiety into N-acylsulfonamides via Arbuzov reaction

  图形摘要 摘要 本研究描述了一种合成含有膦酸酯部分的新型 N-酰基磺酰胺的简便方法。N-酰基磺酰胺以氯磺酰基异氰酸酯 (CSI) 为原料，分四步（氨基甲酰化、氨磺酰化、脱保护和酰化）制备。亚磷酸三甲酯已用于通过 Arbuzov 反应将膦酸酯部分引入 N-酰基磺酰胺中。